Neurobiological Technologies, Inc.

NTII · OTC
Analyze with AI
9/30/2009
6/30/2009
3/31/2009
12/31/2008
Operating Activities
Net Income$5$14-$0-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$3-$20-$3$2
Other Non-Cash-$0$1$0$0
Operating Cash Flow$2-$5-$3-$5
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$11-$9-$14$0
Inv. Sales/Matur.$10$16$16$5
Other Inv. Act.$0-$0$0-$19
Investing Cash Flow-$1$7$2-$14
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$1$2-$1-$19
Supplemental Information
Beg. Cash$8$6$7$26
End Cash$10$8$6$7
Free Cash Flow$2-$5-$3-$5